Received Sep 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
COVID; COVID; This is a spontaneous report received from a Consumer or other non HCP. An 81-year-old female patient received BNT162b2 omicron (lp.8.1) (COMIRNATY (2025-2026 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "stage 4 Cancer" (unspecified if ongoing), notes: stage 4 Cancer. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Primary Immunization completed), for Covid-19 immunization; Bnt162b2 (DOSE NUMBER UNKNOWN (BOOSTER), SINGLE), for Covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID". Clinical course: Patient with covid and laryngitis. Her doctor gave her a prescription for Paxlovid and the worst part is, she have Laryngitis as part of the COVID, she thought she had a bad cold. Had no idea she had covid. She had a booster shot, Pfizer booster shot. She had all shots and two, she shouldn't be quite so sick. The information on the batch/lot number for BNT162b2 omicron (lp.8.1) will be requested and submitted if and when received.
Medical History/Concurrent Conditions: Cancer (stage 4 Cancer)